Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
STXS
#3668
Stereotaxis, Inc. Common Stock
2.020
0
USD
+4.39%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+4.39%
Aylık Değişim
+4.68%
6 aylık değişim
-2.88%
Yıllık Değişim
-2.88%
Önceki Kapanış
1.935
0
Open
2.010
0
Bid
Ask
Low
2.000
0
High
2.040
0
Hacim
143
Piyasalar
ABD Borsası
Sağlık Hizmetleri
STXS
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
73.76 M
74.64 M
75.05 M
82.13 M
85.98 M
97.25 M
—
Valuation ratios
Enterprise value
333.66 M
424.02 M
149.02 M
133.76 M
183.82 M
210.25 M
815.97 M
Price to earnings ratio
-46.27
-38.75
-8.08
-6.93
-7.6
-9.2
-33.29
Price to sales ratio
13.87
13.38
5.58
5.42
7.03
6.37
26.44
Price to cash flow ratio
-105.44
-159.02
-18.98
-16.51
-22.86
-15.29
-89.16
Price to book ratio
10.7
13.85
6.06
9.23
31.94
15.52
45.41
Enterprise value to EBITDA ratio
-51.34
-33.62
-8.28
-6.55
-7.97
-10.47
-37.78
Profitability ratios
Return on assets %
-0.12
-0.18
-0.34
-0.49
-0.51
-0.41
-0.47
Return on equity %
-0.19
-0.32
-0.69
-1.27
-3.95
-1.61
-6.09
Return on invested capital %
-227.69
-373.1
-434.78
-508.83
-402.05
-263.14
—
Gross margin %
71.04
66.36
64.51
53.32
52.85
51.98
208.46
Operating margin %
-25.15
-36.81
-65.58
-78.37
-89.6
-67.32
-273.94
EBITDA margin %
-24.42
-36.54
-62.84
-73.33
-83.57
-61.17
-232.91
Net margin %
-24.9
-30.61
-63.89
-74.33
-87.08
-65.9
-268.27
Liquidity ratios
Quick ratio
3.64
3.54
2.47
1.88
0.84
1.09
3.15
Current ratio
3.88
3.87
3.03
2.51
1.22
1.51
4.95
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.54
0.6
0.5
0.58
0.62
0.66
0.72
Solvency ratios
Debt to assets ratio
0.04
0
—
—
—
—
—
Debt to equity ratio
0.06
0
—
—
—
—
—
Long term debt to total assets ratio
0.02
0
—
—
—
—
—
Long term debt to total equity ratio
0.03
0
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.05
-0.04
-0.11
-0.11
-0.1
-0.15
-0.15
EBIT per share
-0.09
-0.17
-0.24
-0.26
-0.28
-0.24
-0.24
EBITDA per share
-0.09
-0.17
-0.24
-0.25
-0.27
-0.22
-0.21
Total debt per share
0.03
0
—
—
—
—
—
Cash per share
0.6
0.51
0.37
0.25
0.14
0.15
0.46
Net current asset value per share
0.72
0.68
0.57
0.41
0.31
0.37
1.21
Tangible book value per share
0.48
0.45
0.35
0.2
-0.06
0.04
-0.21
Working capital per share
0.54
0.5
0.38
0.25
0.06
0.13
0.23
Book value per share
0.48
0.45
0.35
0.2
0.07
0.15
0.27
Haberler
Stereotaxis, Robocath’ı 45 milyon dolara satın alacak
Shield Therapeutics gelirini %56 artırdı, nakit pozitife döndü
Stereotaxis, Synchrony kateter laboratuvar sistemi için FDA onayı aldı
Citizens, Stereotaxis hissesi için görünümünü yükseltti
Stereotaxis: Medical Robotics Upside Offsets Cash Burn And Execution Risks (NYSE:STXS)
Stereotaxis, Inc. (STXS) Q4 2025 Earnings Call Transcript
Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates
Stereotaxis kazancı beklentilere uygun, kâr ise beklentilere göre düşük
Stereotaxis earnings matched, revenue fell short of estimates
Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Beats Revenue Estimates
Can Digital Subscriptions Become ISRG's New Revenue Stream in 2026?
OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates